MicroRNAs May Predict Pancreatic Cancer Risk Years Before Diagnosis

  • 📰 Medscape
  • ⏱ Reading Time:
  • 58 sec. here
  • 23 min. at publisher
  • 📊 Quality Score:
  • News: 99%
  • Publisher: 55%

Malignant Pancreatic Neoplasm News

Pancreatic Cancer,Cancer Of The Pancreas,Genomics

Expression levels of several microRNAs in plasma samples can help predict the onset of pancreatic cancer up to 5 years prior to clinical diagnosis.

Early detection of pancreatic cancer could improve patient prognosis, but clinically viable biomarkers are lacking. In a two-stage study, researchers screened and validated circulating miRNAsas biomarkers for early detection using prediagnostic plasma samples from 462 case-control pairs across multiple cohorts.

The discovery stage included 185 pairs from the PLCO Cancer Screening Trial, and the replication stage included 277 pairs from Shanghai Women's/Men's Health Study, Southern Community Cohort Study, and Multiethnic Cohort Study. Overall, 798 plasma microRNAs were measured using the NanoString nCounter Analysis System, and odds ratios for pancreatic cancer risk were calculated on the basis of miRNA concentrations.In the discovery stage, the researchers identified 120 miRNAs significantly associated with pancreatic cancer risk.

Three of these miRNAs showed consistent significant associations in the replication stage. Specifically, hsa-miR-199a-3p/hsa-miR-199b-3p and hsa-miR-191-5p were associated with a 10%-11% lower risk for pancreatic cancer , and hsa-miR-767-5p was associated with an 8% higher risk for pancreatic cancer within 5 years of the blood draw.

In age-stratified analyses, hsa-miR-767-5p along with four other miRNAs — hsa-miR-640 , hsa-miR-874-5p , hsa-miR-1299 , and hsa-miR-449b-5p — were associated with an increased risk for pancreatic cancer among patients diagnosed at age 65 or older.

Source: Healthcare Press (healthcarepress.net)

Pancreatic Cancer Cancer Of The Pancreas Genomics Genomic Medicine Cancer Malignant Neoplasia Carcinoma Malignant Neoplasm Cancer Risk Mirna Microrna Leukemia Leukaemia Blood Cancer Plasma Biomarker Biological Marker Multi-Biomarker Disease Activity MBDA Multibiomarker Disease Activity Blood

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 386. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pancreatic Fat Is the Main Driver for Exocrine and Endocrine Pancreatic DiseasesThe diffused presence of fat within the pancreas was the single most important driver for diseases of both the exocrine pancreas and endocrine pancreas, a recent study reported.
Source: Medscape - 🏆 386. / 55 Read more »

Blood Test May Predict Multiple Sclerosis Disease Path and TreatmentA blood test could one day determine a multiple sclerosis patient’s likely disease path and suggest individualized treatment courses, new research suggests.
Source: WebMD - 🏆 709. / 51 Read more »

Distinct Immune Markers in Blood May Help Predict Multiple Sclerosis Disease TrajectoriesA new study suggests that multiple sclerosis (MS) has three distinct subtypes based on immune markers in patient's blood, each with slightly different disease trajectories and responses to therapy. Determining a patient's blood 'immune signature' before starting immunomodulatory therapy may help predict clinical disease trajectories and lead to more personalized treatment decisions.
Source: Medscape - 🏆 386. / 55 Read more »

New Pancreatic Cancer Test Shows Promising ResultsResearchers have developed a new test for pancreatic cancer that shows promising results in initial and validation tests. The test, based on microRNAs and cell-free DNA markers, has an accuracy of about 90% for stage I/II pancreatic cancer. Adding a well-known marker of pancreatic cancer further boosts the test's accuracy to 97%. The researchers believe the test could be used for screening high-risk patients.
Source: Medscape - 🏆 386. / 55 Read more »

'Autoantibody Signature' Flags MS Years Before Symptom OnsetA unique autoantibody signature of multiple sclerosis may predict the disease years before individuals become symptomatic.
Source: Medscape - 🏆 386. / 55 Read more »

Nano-drugs hitching a ride on bacteria could help treat pancreatic cancerMany pancreatic tumors are like malignant fortresses, surrounded by a dense matrix of collagen and other tissue that shields them from immune cells and immunotherapies that have been effective in treating other cancers.
Source: physorg_com - 🏆 388. / 55 Read more »